Cistanche RunTong oral liquid

Cistanche RunTong oral liquid is a Traditional Chinese Medicine (TCM) therapeutic developed by Jiangsu Kanion Pharmaceutical for the treatment of functional constipation. It is specifically indicated for the "Yang-deficiency" subtype, a TCM classification characterized by symptoms such as cold extremities and sluggish bowel function. The formulation likely centers on *Cistanche deserticola* (Rou Cong Rong), a well-known herbal ingredient in Chinese medicine used to tonify the kidneys and lubricate the large intestine. As of 2023, the drug is being evaluated in a Phase 2, randomized, double-blind, placebo-controlled clinical trial in China (CTR20230059) to establish its efficacy, safety, and optimal dosing regimen in adult patients.

Brand names

Cistanche RunTong oral liquid

Other names

Cistanche Runtong Koufuye